ELISA assays confirmed that CXCL7 overexpression elevated SAM levels, and this effect was blocked by PHGDH inhibition (Fig. 4G), suggesting that CXCL7-induced serine metabolism in tumor cells mediates SAM secretion. The gene discussed is PHGDH; the disease is neoplasm.